Moleculin Biotech, Inc.

MBRX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $19.6M

Liabilities Breakdown FY2018

Total Liabilities: $5.3M